Recombinant Rabbit Anti-MAPT (phospho Thr181) Antibody (clone R06-7C6)

CAT#: VS3-FY897

This product is a recombinant rabbit antibody that recognizes MAPT. This antibody has been reported for use in Western Blot, Immunoprecipitation. The clone R06-7C6 is specific for human MAPT. The antigen is a synthetic phosphopeptide corresponding to residues surrounding thr181 of human tau.

Gene Expression Tested Data
Figure 1 IF staining of human cell line BJ Figure 2 IF staining of human cell line BJ Figure 3 Cerebral cortex Figure 4 Colon Figure 5 Kidney Figure 6 RNA cell line category: Group enriched (HDLM-2, SCLC-21H, T-47d)
Figure 1. Recombinant Rabbit Anti-MAPT (phospho Thr181) Antibody (clone R06-7C6) in WB.

Specifications

  • Immunogen
  • A synthetic phosphopeptide corresponding to residues surrounding Thr181 of human Tau.
  • Host Species
  • Rabbit
  • Type
  • Rabbit IgG
  • Specificity
  • Human MAPT
  • Species Reactivity
  • Human
  • Clone
  • R06-7C6
  • Conjugate
  • Unconjugated
  • MW
  • Calculated MW: 79 kDa; Observed MW: 50-80 kDa

Product Property

  • Purification
  • Affinity Purified
  • Purity
  • >95% as determined by SDS-PAGE
  • Buffer
  • 50 mM Tris-Glycine, pH 7.4, 0.15 M NaCl, 40% glycerol, 0.05% BSA
  • Preservative
  • 0.01% Sodium azide
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • Western Blot: 1/500-1/1000
    Immunoprecipitation: 1/20

Target

  • Alternative Names
  • Microtubule Associated Protein Tau; G Protein Beta1/Gamma2 Subunit-Interacting Factor 1; Protein Phosphatase 1, Regulatory Subunit 103; Neurofibrillary Tangle Protein; Paired Helical Filament-Tau; PHF-Tau; MAPTL; MTBT1; TAU
  • Cellular Localization
  • Cell membrane, Cell projection, Cytoplasm, Cytoskeleton, Membrane, Microtubule, Secreted
  • Post Translation Modifications
  • Phosphorylation at serine and threonine residues in S-P or T-P motifs by proline-directed protein kinases (PDPK1, CDK1, CDK5, GSK3, MAPK) (only 2-3 sites per protein in interphase, seven-fold increase in mitosis, and in the form associated with paired helical filaments (PHF-tau)), and at serine residues in K-X-G-S motifs by MAP/microtubule affinity-regulating kinase (MARK1, MARK2, MARK3 or MARK4), causing detachment from microtubules, and their disassembly (PubMed:7706316, PubMed:23666762).
    Phosphorylation decreases with age. Phosphorylation within tau/MAP's repeat domain or in flanking regions seems to reduce tau/MAP's interaction with, respectively, microtubules or plasma membrane components (PubMed:7706316).
    Phosphorylation on Ser-610, Ser-622, Ser-641 and Ser-673 in several isoforms during mitosis. Phosphorylation at Ser-548 by GSK3B reduces ability to bind and stabilize microtubules. Phosphorylation at Ser-579 by BRSK1 and BRSK2 in neurons affects ability to bind microtubules and plays a role in neuron polarization. Phosphorylated at Ser-554, Ser-579, Ser-602, Ser-606 and Ser-669 by PHK. Phosphorylation at Ser-214 by SGK1 mediates microtubule depolymerization and neurite formation in hippocampal neurons. There is a reciprocal down-regulation of phosphorylation and O-GlcNAcylation. Phosphorylation on Ser-717 completely abolishes the O-GlcNAcylation on this site, while phosphorylation on Ser-713 and Ser-721 reduces glycosylation by a factor of 2 and 4 respectively. Phosphorylation on Ser-721 is reduced by about 41.5% by GlcNAcylation on Ser-717. Dephosphorylated at several serine and threonine residues by the serine/threonine phosphatase PPP5C.
    Polyubiquitinated. Requires functional TRAF6 and may provoke SQSTM1-dependent degradation by the proteasome (By similarity).
    PHF-tau can be modified by three different forms of polyubiquitination. 'Lys-48'-linked polyubiquitination is the major form, 'Lys-6'-linked and 'Lys-11'-linked polyubiquitination also occur.
    O-glycosylated. O-GlcNAcylation content is around 8.2%. There is reciprocal down-regulation of phosphorylation and O-GlcNAcylation. Phosphorylation on Ser-717 completely abolishes the O-GlcNAcylation on this site, while phosphorylation on Ser-713 and Ser-721 reduces O-GlcNAcylation by a factor of 2 and 4 respectively. O-GlcNAcylation on Ser-717 decreases the phosphorylation on Ser-721 by about 41.5%.
    Glycation of PHF-tau, but not normal brain TAU/MAPT. Glycation is a non-enzymatic post-translational modification that involves a covalent linkage between a sugar and an amino group of a protein molecule forming ketoamine. Subsequent oxidation, fragmentation and/or cross-linking of ketoamine leads to the production of advanced glycation endproducts (AGES). Glycation may play a role in stabilizing PHF aggregation leading to tangle formation in AD.
  • Function
  • Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed:21985311).
    The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed:21985311, PubMed:32961270).
    Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for VS3-FY897. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Secondary Antibody

Isotype Control

See other products for "MAPT"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
BRD-0733MZ Chicken Anti-TAU Polyclonal IgY ICC, IF, IHC, WB Chicken antibody
CAT Product Name Application Type
PABX-174 Recombinant Mouse Anti-Tau5 Antibody WB, ELISA, Neut, FuncS IgG
PABX-174-S (P) Recombinant Mouse Anti-Tau5 Antibody scFv Fragment WB, ELISA, Neut, FuncS scFv
PABX-174-F (E) Recombinant Mouse Anti-Tau5 Antibody Fab Fragment WB, ELISA, Neut, FuncS Fab
CAT Product Name Application Type
VS-0424-XY182 AbPlus™ Anti-MAPT Magnetic Beads (VS-0424-XY182) IP, Protein Purification
CAT Product Name Application Type
VS-0325-FY121 Human Anti-MAPT (clone IPN002) scFv-Fc Chimera ELISA, FC Human IgG1, scFv-Fc
CAT Product Name Application Type
VS-0625-YC216 Recombinant Anti-MAPT Eliminating Antibody, pH-Sensitive (VS-0625-YC216) Antigen-Sweeping In Vivo. Mouse IgG
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare